CLINICAL_TRIALS
trial_result
· 2014-02-03
Clinical Trial Update: A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer [Phase 1]
Summary
A Phase 1 study evaluating the maximum tolerated dose of Elesclomol Sodium when given with a fixed dose of Docetaxel and Prednisone in patients with metastatic …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Synta Pharmaceuticals Corp. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED